Follows people with sarcoma over time after diagnosis and treatment
Studies how sarcoma and its treatment affect patients over their lifetime.
Key facts
- Who runs it
- Vanderbilt-Ingram Cancer Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
- Status
- Recruiting
- People taking part
- 2,100 people, planned
- Started
- 1 Apr 2022
- Expected to end
- Apr 2029
- Type of study
- Observational
- Treatments tested
- Surveys
- Blood Collection
- Saliva Collection
- Urine Collection
- Stool Collection
- Tissue collection
- Physical Activity Monitoring
- Record updated
- 19 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people of any age who have ever had sarcoma, whether or not the disease is still present. For children, a parent or main caregiver and siblings aged 8 or older can also join.
- Age
- Any age. Siblings of child patients must be 8 years or older.
- Sex
- All sexes can join.
- Disease stage
- A history of sarcoma, with or without evidence of persistent disease.
The registry criteria, word for word
Show all 4 criteriaShow less
Other criteria
- Patients at any age with a history of sarcoma, with or without evidence of a persistent disease
- For pediatric patients
- Parent/primary caregiver of patient
- Sibling of patient aged 8 years or older
Where in United States
- Vanderbilt University/Ingram Cancer CenterNashville, United StatesContact: Vanderbilt-Ingram Service for Timely AccessTaking people
About the trial
What the trial wants to find out
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
The group in the trial
- Observational
Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.
Treatment: Surveys, Blood Collection, Saliva Collection, Urine Collection, Stool Collection, Tissue collection, and Physical Activity Monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
- Plain-language title
- Follows people with sarcoma over time after diagnosis and treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 19 September 2025